Localization of authentic thromboxane A2/prostaglandin H2 receptor in the rat kidney  by Bresnahan, Barbara A. et al.
Kidney International, Vol. 49 (1996), PP. 1207—1213
Localization of authentic thromboxane A2/prostaglandin H2
receptor in the rat kidney
BARBARA A. BRESNAHAN, Gu C. LE BRETON, and ELIAS A. Lios
Nephrology Division, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, and Department of Pharmacology, University of
Illinois, Chicago, illinois, USA
Localization of authentic thromboxane A2lprostaglandin H2 receptor in
the rat kidney. Using a polyclonal antibody against authentic thromboxane
A2/prostaglandin H2 (TxA2/PGH2) receptor protein, we assessed the
distribution of this receptor in the normal rat kidney by routine methods
of immunofluorescence microscopy. The receptor localized both in gb-
meruli and in tubules. In the former, the distribution of the receptor was
most prominent along the lumen of glomerular capillary ioops. Parietal
epithelial cells of the Bowman's capsule, podocytes and mesangial cells
also demonstrated immunostainable receptor. In the tubules, the receptor
localized most prominently at the base of the brush border of proximal
tubules and at the luminal surface of thick ascending limbs and distal
convoluted tubules. These observations point to sites that are likely to be
targeted by thromboxane A2 in forms of renal injury characterized by
enhanced synthesis of this eicosanoid.
Multiple studies addressing the synthesis and cell origin of
thromboxane A2 (TxA2) by renal tissue have employed the rat
kidney. These studies have shown that TxA2 is mainly produced in
the glomerulus and that its production is either minimal or
undetectable in renal tubular epithelium [1, 2]. The cellular origin
of glomerular TxA2 synthesis was further explored by assessing its
production in cultured glomerular cells, and it was shown that it is
mainly produced by glomerular mesangial cells. Its synthesis
under basal or stimulated conditions in glomerular epithelial or
endothelial cells is minimal or undetectable.
TxA2 is not the major eicosanoid synthesized by normal gb-
meruli or by cultured glomerular cells. Its abundance is substan-
tially lower than that of other eicosanoids such as prostaglandin
(PG) F2,, and PGE2. However, following glomerular injury, produc-
tion of TxA2 by isolated glomeruli is markedly enhanced. This was
shown in a number of experimental models of glomerular injury
including antibody-mediated injury, diabetic glomerulopathy and
renal allograft rejection [reviewed in 3]. In these conditions,
particularly in glomerular immune injury, TxA2 has been shown to
originate from inflammatory cells, mainly activated leukocytes
and platelets, that infiltrate the glomerular structures [4]. Once
released by these cells, TxA2 can act in a paracrine manner on
intrinsic glomerular cells (endothelial, mesangial, and epithelial)
to induce a number of biologic effects. These have best been
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characterized in cultured mesangial cells which possess functional,
high affinity receptor sites for TxA2 [5]. Binding of TxA2 to
mesangial cell receptors induces a number of signaling events and
biologic responses including activation of a phosphatidylinositol-
specific phospholipase C, activation of protein kinase C and
enhanced DNA synthesis [6], contraction [7], and enhanced
production of extracellular matrix [8]. Despite this impressive
array of biologic events induced by TxA2 on glomerular cells, the
localization and distribution of TxA2 receptors in the glomerulus
and the kidney has only recently been explored. Knowledge of the
location and abundance of TxA2 receptors within the kidney will
enhance our understanding of the role of this eicosanoid in renal
physiology and will identify sites of the nephron that are likely to
be targeted by TxA2 in forms of renal injury characterized by
augmented TxA2 production. The present studies employed a
polyclonal antibody raised against authentic thromboxane A2!
prostaglandin H2 (TxA2/PGH2) receptor protein to localize this
receptor in the normal rat kidney.
Methods
Antibody against native TxA2/PGH2 receptor protein
Two polyclonal antibodies developed by Borg et al [9, 10] were
employed: (a) an antibody raised against the TxA2/PGH2 receptor
protein [9]. The 55 kDa receptor protein was purified from
platelets using ligand affinity chromatography [10]. Briefly, solu-
bilized platelet membranes were subjected to affinity chromatog-
raphy and eluted with the TxA2/PGH2 receptor antagonist
BM13.177 [111. The BM13.177 eluate fractions containing recep-
tor protein were lyophilized and subjected to SDS-PAGE using
7.5% slab gels. The 55 kDa area of the gel was then sliced and the
receptor protein was electrophoretically eluted and used for
immunizations to raise the anti-receptor protein antibody. In
immunobbotting experiments, this antibody reacted with a single
55 kDa protein corresponding to the molecular mass of the
purified receptor protein. (b) An antibody raised against a de-
capeptide segment in the C-terminal region of the intracellular
domain of the receptor corresponding to amino acid residue 314
through 323. IgG specific for this peptide was purified by affinity
chromatography employing the peptide as the immobilized ligand.
By ELISA, this antibody displayed immunoreactivity toward its
synthetic antigen (based on the published sequence of the placen-
tal TxA2IPGH2 receptor), toward solubilized platelet membranes
and toward affinity-purified TxA2/PGH2 receptor protein. By
Western blot analysis, the antibody reacted with the purified
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Fig. 2. High magnification view (40x) of localization of the TxA2/PGH2 receptor in a glomerulus and surrounding tubules. Localization in glomerular
parietal epithclial cells, a podocyte (arrow) and in the brush border of tubules is visible.
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Fig. 3. Immunolocalization of the TxA2IPGH2 receptor in glomerular structures using a polyclonal antibody against receptor protein. Distribution of the
receptor is most prominent in the wall of glomerular capillary loops where it is apparent in a linear continuous pattern surrounding the capillary lumen.
The receptor also localized in epithelial cells (solid arrow), and in mesangial areas (open arrowhead) (magnification 40X)
platelet TxA2/PGH2 receptor protein (55 kDa), and recognized a
single band (55 kDa) in solubilized platelet membranes [12].
Preparation of kidney for immunohistology
Male Sprague-Dawley rats (200 to 350 g, Harland Industries,
Madison, WI, USA) were anesthesized with mactin and main-
tained at 37°C on a contast temperature table. The kidneys were
perfused in situ via a canula inserted in the inferior abdominal
aorta while the aorta above the renal arteries was tied off. The
kidneys were perfused via a pump that delivered perfusate under
30 mm Hg. Perfusions were performed sequentially with 50 ml
heparinized saline, 100 ml 1% paraformaldehyde and 2.5% glu-
taraldehyde in phosphate buffered saline, pH 7.4, followed by
10% sucrose. The animals were subsequently nephrectomized and
the cortical tissue placed in O.C.T. (Optimium Cutting Temper-
ature Compound, American Scientific Products, McGaw Park, IL,
USA) at —70°C. Cryostat sections, 4 to 5 m, were incubated at
room temperature under moisture for one hour with the TxA2/
PGH2 receptor antibody diluted (1:100) in phosphate buffered
saline. Sections were subsequently washed, incubated for 30
minutes with fluorescein isothiocyanate-labeled goat anti-rabbit
IgG (Cappel, West Chester, PA, USA) and examined by immu-
nofluorescence microscopy. To demonstrate specific binding of
the TxA2/PGH2 receptor antibody, control sections were incu-
bated in a similar manner with antibody that had been preab-
sorbed for 18 hours at room temperature with the C-terminal
receptor region decapeptide.
Results
Figure 1 shows distribution of the TxA2/PGH2 receptor in a
renal cortical section. The receptor localized both in glomeruli
and in the luminal surface of tubules. A high magnification view of
localization of the receptor in a glomerulus and surrounding
tubules is shown in Figure 2. Localization in glomerular parietal
epithelial cells, in a podocyte (arrow) and in the brush border of
the surrounding tubules is apparent.
In Figure 3, binding and distribution of the anti-TxA2IPGH2
receptor antibody in glomerular structures is shown. Localization
of the receptor was most prominent in the wall of glomerular
capillaries in a linear continuous pattern surrounding the capillary
lumen. Localization of the receptor was also apparent in podo-
cytes and mesangial areas.
In Figure 4, binding of the anti-TxA2/PGH2 receptor antibody
(Fig. 4A) and of the anti-C-terminal region decapeptide (Fig. 4B)
in glomerular capillaries is shown. A similar pattern of distribu-
tion around the capillary lumen was obtained.
Figure 5 demonstrates the effect of absorption of the anti-
decapeptide antibody with the C-terminal receptor region de-
capeptide antigen. When antibody absorbed with the peptide
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Fig. 4. Binding of the anti-TxA2/PGH2 receptor antibody (A), and of the antibody raised against the C-terminal receptor region decapeptide (B) in glomerular
capillaty loops (magnification X40).
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Fig. 5. Effect of absorption of the anti-decapeptide antibody with the C-terminal receptor region decapeptide antigen. A. Binding of antibody to glomerular
structures is shown. B. The effect of absorption of the antibody with the decapeptide antigen on binding of this antibody is shown. (Magnification X20)
antigen was used, there were no positive binding signals (Fig. 5B)
as compared to non-absorbed receptor antibody (Fig. 5A).
In Figure 6 localization of the TxA2IPGH2 receptor is shown in
renal cortical tubules. The receptor localized at the base of the
brush border of proximal tubules (Fig. 6A), and also at or near the
luminal surface of thick ascending or distal convoluted tubules
(Fig. 6B). In the latter, vesicular structures demonstrating positive
immunostaining for the receptor were apparent at or just below
the luminal surface and within the tubular cells (Fig. 6B).
Discussion
Although the role of TxA2 in regulating the glomerular micro-
circulation and in the pathophysiology of various forms of gb-
merular injury has been extensively studied, studies characterizing
the distribution of thromboxane A2 receptor in the kidney are only
recently emerging. Abe and coinvestigators have recently described
the intrarenal expression of the thromboxane receptor in the rat
kidney [13]. Using a rat kidney thromboxane receptor cDNA, they
examined expression of thromboxane receptor mRNA in the
kidney by methods of in situ hybridization or reverse transcrip-
tion-polymerase chain reaction (RT-PCR) applied to microdis-
sected nephron segments. They demonstrated that the thrombox-
ane receptor was expressed specifically in the renal glomerulus, in
arterial smooth muscle cells and in the transitional cell epithelium
of the renal pelvis. Mannon, Coffman and Mannon employed a
receptor autoradiography approach using the radio labeled
thromboxane receptor agonist [1251][1S-1-alpha, 2-beta (5z], 3-al-
pha-(1 E, 3R*), 4-alpha] -7- [3-(3-hydroxy-4-(4'-iodophenoxy-1-
butenyl)-7-oxabicycbo - [2.2.1] heptan - 2 yl] -5-heptenoic acid
(1-BOP), and detected specific binding of this agonist throughout
the kidney, the highest density of specific binding being localized
to the medulla, glomeruli and to small and medium sized arteries.
There was a paucity of receptors in the juxtamedullary region and
in the papilla [14].
To further explore the localization of the thromboxane receptor
in the kidney, we performed the present immunolocalization
studies using a polycbonal antibody raised against authentic TxA2/
PGH2 receptor protein purified by ligand affinity chromatography.
This antibody reacts with purified platelet TxA2/PGH2 receptor
protein and identifies a single protein band at 55 kDa in solubi-
lized platelet membranes [9, 10]. This 55 kDa protein specifically
binds the thromboxane A2 receptor antagonist [3H] SQ29548, and
immunohistochemical studies using an antibody against this pro-
tein (employed in the present studies) have localized the TxA2/
PGH2 receptor in rat brain, rabbit aorta and human platelets [9].
Our results indicate that the native TxA2/PGH2 receptor pro-
tein is distributed in glomeruli and in tubules of the rat kidney
cortex. In the glomerulus, its localization was apparent in capillary
loops as a linear continuous pattern surrounding the lumen of the
capillaries (best shown in Fig. 4A), in parietal epithelial cells of
the Bowman's capsule and podocytes (Fig. 2), and in the mesan-
gium (Fig. 3). Immunolocalization was most prominent and
distinct in capillary loops rather than the mesangium (Figs. 3 and
4). The binding pattern of the antibody raised against the C-
terminal receptor region decapeptide to glomerular capillaries
was similar to that obtained with the anti-TxA2/PGH2 receptor
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Fig. 6. Immunolocalization of the TxA,/PGH, receptor in renal cortical tubules. A. Prominent localization of the receptor at the base of the brush border
of a proximal tubule is apparent. B. Localization of the receptor in a stippled pattern at the luminal surface of a thick ascending loop or distal convoluted
tubule. In this tubule the receptor is also localized within vesicular formations (magnification x40).
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protein (Figs. 4 A, B). The anti-decapeptide antibody employed
does not block platelet aggregation induced by ADP or by the
TxA2 mimetic U-46619, nor does it block binding of the TxA2
receptor antagonist SQ-29,548 to the solubilized receptor [12].
Therefore, this antibody identifies epitopes that are separate from
the TxA2/PGH2 binding domain of the receptor.
The apparent differences in sites of localization observed in the
present study and that by Abe et a! [13] are most likely due to the
different methodologic approaches employed. Thus, the inability
to detect thromboxane receptor mRNA in isolated tubular seg-
ments using in situ hybridization and RT-PCR methods in the
studies by Abe et al may be due to the existence of TxA2/PGH2
receptor subtypes that cannot be detected by the cRNA fragment
or oligonucleotide primers employed in these studies. The exis-
tence of such a subtype is supported by an earlier report which
described the presence of immunoreactive TxA2/PGH2 receptors
in rat brain with different apparent molecular weights, that is, 55
kDa and 52 kDa [91. Results obtained with in situ hybridization
and RT-PCR methods are dependent on the specific sequences
(and lengths) selected as fragments or primers. Consequently,
positive results can be taken as evidence for homology with a
receptor, whereas negative results cannot be taken as proof for
the absence of a subtype of that receptor.
Although there is a plethora of studies characterizing the
presence of functional TxA2 receptors in cultured mesangial cells,
definitive studies showing the presence of TxA2 receptors in
glomerular epithelial cells are lacking. To this extent, our obser-
vations indicate that glomerular epithelial cells do demonstrate
immunostainable TxA2/PGH2 receptor. These include both pan-
eta! epithelial cells of the Bowman's capsule and glomerular
podocytes (Figs. 2 and 3),
With respect to tubular localization of native TxA2 receptor,
our observations identify prominent expression of the receptor at
the base of the brush border of proximal tubules where it is
distributed in a linear pattern (Fig. 6A), and at the luminal surface
and within vesicular formations of thick ascending or distal
convoluted tubules (Fig. 6B). These tubules are likely to be thick
ascending or distal convoluted as they lack intercalating cells,
which typically bulge into the lumen and arc only present in
connecting tubular segments and collecting ducts. The functional
significance of the differences in the pattern of distribution of the
native TxA2IPGH2 receptor in renal tubules awaits investigation.
The tubular epithelium is likely to get exposed to substantial
amounts of TxA2 generated by inflammatory cells infiltrating the
glomerular capillary in the course of various forms of glomerular
injury. Filtration of thromboxane following injury and binding to
renal tubular epithelium is quite likely to occur in view of the
presence of TxA2 receptors in this epithelium. The pathophysio-
logic significance of this event is only speculative. Studies assess-
ing signalling events and physiologic responses generated as a
result of TxA2 binding to renal tubular epithelial cells are lacking.
Possible effects may include activation by TxA, of phospholipase
C and protein kinase C, as we and others have demonstrated in
glomerular mesangial cells [5, 6], thereby modulating transport
mechanisms of this epithelium.
In summary, using a polyclonal antibody against authentic
TxA2/PGH2 receptor protein we have localized this receptor in
the normal rat glomerulus and tubular epithelium. Prominent
sites of localization were the glomerular capillaries and glomeru-
lar epithelial cells, the base of brush border of proximal tubular
cells, and the luminal surface of thick ascending or distal convo-
luted tubules.
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